EGFR and head and neck squamous cell carcinoma: EGFR participates in SCCHN autocrine stimulation, and overexpression of EGFR and its primary ligand in humans, transforming growth factor alpha (TGF-α), have been correlated with poor outcomes for patients receiving therapy [5].